Rapid Response COVID-19 Antigen Rapid Test Device Kit (5-PACK)

Price:

0.00 C$


Rapid Response COVID-19 Antigen Rapid Test Device Kit (25-PACK)
Rapid Response COVID-19 Antigen Rapid Test Device Kit (25-PACK)
Not Available For Sale
Safety glasses
Safety glasses
5.95 C$
5.95 C$

Rapid Response COVID-19 Antigen Rapid Test Device Kit (5-PACK)

https://www.sanistock.ca/web/image/product.template/1469/image_1920?unique=7ddcc01

The Rapid Response COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions. In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test.

The Rapid Response COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions. In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test.

0.00 C$ 0.0 CAD 0.00 C$

0.00 C$

Not Available For Sale


  • Format
  • Brand

This combination does not exist.



Share :

Terms and Conditions
Shipping: 2-3 Business Days

Format 5 tests/Box
Brand ABC Medical

The Rapid Response COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions. In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test.

Schools
Buildings
Food industry
Shop/Store
Hotel
Airport
  • Health Canada Authorized testing device
  • Easy-to-use test
  • Results in 15 minutes
  • Individually packed test devices
  • Also available in 25 tests/box
Quantity5 tests/Box
Format(s)Cassette

Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but other diagnostic information is necessary to determine infection status. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or partient management decisions, including infection control decisions.